Europe Dialyzer Market

Europe Dialyzer Market Size (2023 to 2028)

The Europe dialyzer Market was worth USD 1066.12 million in 2023 and is estimated to be growing at a CAGR of 6.16%, to reach USD 1437.51 million by 2028.

A dialyzer is a medical device that replaces kidney function by using an artificial membrane to remove excess water and metabolic wastes from the blood. Dialyzers are primarily used by healthcare professionals for hemodialysis. Patients may need this treatment three to four times a week. According to the treatment, it is divided into intermittent hemodialysis treatment and continuity hemodialysis treatment.

The rapidly rising frequency of chronic kidney diseases and end-stage renal disease is predicted to boost dialyzer adoption. The expanding acceptance of hemodialysis equipment is projected to be aided by the development of healthcare infrastructure, which provides the necessary technological environment and resources to conduct dialyzer sessions. Also, the increasing incidences of kidney shortages for transplantation are one of the driving the European dialyzer market.

End-stage renal disease is projected to become more common as the incidence of risk factors associated with the disease, such as diabetes, hypertension, and cancer, rises.

In addition, the high efficiency of high-flux dialyzers to remove big toxin molecules during the dialyzer is expected to increase the growth of high-flux dialyzers. Furthermore, the increased compatibility of high-flux dialyzers with developing hemodialyzer technologies like hemodiafiltration and online hemodialysis is expected to drive high-flux dialyzer growth in the regional market by 2027. 

On the other hand, the Europe dialyzer market is growing due to many patients suffering from diabetes and hypertension. Furthermore, due to the risks of kidney transplantation, people with chronic illnesses prefer dialysis versus transplantation. In addition, an increasing frequency of renal disease around the world, a growing elderly population, efficient treatments, and changing lifestyles are driving the Europe dialyzer market.

Furthermore, throughout the forecast period, favorable reimbursement policies in healthcare are expected to drive the adoption of dialyzer equipment. In addition, increasing investments and funding by the government and private organizations for product development, including research and development activities, are expected to encourage the growth of European dialyzer market. 

However, Dialysis has high equipment and maintenance costs is expected to restrain the market growth. In addition, the challenges and risks involved with hemodialysis procedures, such as severe anemia and fluid overload, will limit the Europe dialyzer market.

This research report on the European dialyzer market has been segmented and sub-segmented into the following categories:

By Type

• High-Flux
• Low-Flux

By End-User

• In Center Dialyzer
• Home Dialyzer

By Country:

• United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands and
• Rest of Europe

The European dialyzer market has the largest market share, and it is anticipated to continue its growth in the coming years. Europe Dialyzer Market is expected to grow at a CAGR of 5.4% and to reach USD 5.59 billion by 2027, from USD 4.30 billion in 2022 during the forecast period 2022 to 2027. The region's diabetes, hypertension, and end-stage renal disease (ESRD) rates are on the rise. The regional market growth is attributed to the availability of well-established healthcare infrastructure, the high prevalence of kidney failures, and an increasing number of people infected with various chronic diseases. Countries such as Germany, the UK, Italy, France, and Spain largely contribute to the European regional market growth. 

Germany accounted for the largest market share of the Europe Dialyzer market, and it is projected to record a predominant share during the forecast period. The significant increase in the incidence of end-stage renal disease (ESRD), hypertension, diabetes, and other diseases contributes to the growth of this market.

On the other hand, the United Kingdom is likely to witness a significant share of the European dialyzer market during the forecast period. The improving the healthcare sector, technological advancements in the healthcare sector, and increasing healthcare spending fuelling the market growth. 

KEY MARKET PLAYERS:

Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Medtronic Plc, JMS Co.Ltd., Kawasumi Laboratories Inc., Fresenius Medical Care AG, and Co. KGaA, Nikkiso Co. Ltd., Nipro Corp., and Toray Industries Inc. are some of the key players operating in the Europe dialyzer market profiled in this report.